ACE and heart failure: The typical constellation of biochemical abnormalities that characterize heart failure increases angiotensin-converting enzyme activity, increases oxidative stress and raises endothelin-1 levels, leading to a reduction in endothelium-derived nitric oxide (NO) bioavailability and increased vasoconstrictor tone.